Yiju Cheng

740 total citations · 1 hit paper
20 papers, 539 citations indexed

About

Yiju Cheng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Hepatology. According to data from OpenAlex, Yiju Cheng has authored 20 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 4 papers in Hepatology. Recurrent topics in Yiju Cheng's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Eosinophilic Disorders and Syndromes (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Yiju Cheng is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Eosinophilic Disorders and Syndromes (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Yiju Cheng collaborates with scholars based in China and United States. Yiju Cheng's co-authors include Xueke Zhao, Mao Mu, Yumei Yao, Baofang Zhang, Lei Yu, Li Zhu, Quan Zhang, Wenting Yang, Menglin Zhang and Yang Liu and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and World Journal of Gastroenterology.

In The Last Decade

Yiju Cheng

19 papers receiving 531 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice

2023 67 citations Lin Pan, Yiju Cheng et al. Inflammation profile →

Peers

Countries citing papers authored by Yiju Cheng

Since Specialization

Citations

This map shows the geographic impact of Yiju Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiju Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiju Cheng more than expected).

Fields of papers citing papers by Yiju Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiju Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiju Cheng. The network helps show where Yiju Cheng may publish in the future.

Co-authorship network of co-authors of Yiju Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yiju Cheng. A scholar is included among the top collaborators of Yiju Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiju Cheng. Yiju Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of telomere dysfunction and immune infiltration in idiopathic pulmonary fibrosis: new insights from bioinformatics analysis 2024 ·Frontiers in Genetics ·(unknown), (unknown), (unknown), (unknown), Yiju Cheng, (unknown), (unknown)	1
2	Construction and Bioinformatics Analysis of ceRNA Regulatory Networks in Idiopathic Pulmonary Fibrosis 2024 ·Biochemical Genetics ·Menglin Zhang, (unknown), Honglan Zhu, (unknown), Wenting Yang, (unknown), (unknown), Yiju Cheng	0
3	Comprehensive analysis of an endoplasmic reticulum stress-related gene prediction model and immune infiltration in idiopathic pulmonary fibrosis 2024 ·Frontiers in Immunology ·Honglan Zhu, (unknown), Menglin Zhang, Lin Pan, (unknown), (unknown), Ling Gong, Wenting Yang, Daishun Liu, Yiju Cheng	6
4	Identification of immune biomarkers associated with basement membranes in idiopathic pulmonary fibrosis and their pan-cancer analysis 2023 ·Frontiers in Genetics ·(unknown), Lina Chen, Yiju Cheng, Wenting Yang, Honglan Zhu, (unknown), (unknown)	2
5	Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K/Akt/mTOR signaling pathway 2023 ·Scientific Reports ·Wenting Yang, (unknown), Yiju Cheng, (unknown), (unknown), Juan Du, Honglan Zhu, Menglin Zhang, (unknown)	8
6	Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice breakdown → 2023 ·Inflammation ·Lin Pan, Yiju Cheng, Wenting Yang, (unknown), Honglan Zhu, (unknown), Yuquan Zhang, Menglin Zhang	67
7	A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK/ERK/S100A4 signaling pathways 2023 ·BMC Pulmonary Medicine ·(unknown), Lina Chen, Yiju Cheng, Yuquan Zhang, Wenting Yang, Lin Pan, (unknown), Honglan Zhu, Menglin Zhang	2
8	Pacenta polypeptide injection alleviates the fibrosis and inflammation in cigarette smoke extracts‐induced BEAS‐2B cells by modulating MMP‐9/TIMP‐1 signaling 2023 ·Journal of Biochemical and Molecular Toxicology ·Wei Xu, Fuqiang Li, Li Zhu, Mingliang Cheng, Yiju Cheng	6
9	Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK/ERK/S100A4 signalling pathway 2022 ·International Immunopharmacology ·Wenting Yang, Lin Pan, Yiju Cheng, (unknown), Bin Tang, Honglan Zhu, Menglin Zhang, Yuquan Zhang	17
10	Fecal transplantation alleviates acute liver injury in mice through regulating Treg/Th17 cytokines balance 2021 ·Scientific Reports ·Yongmei Liu, (unknown), Zhuo Cheng, Lei Yu, Shuo Cong, Yaxin Hu, Lili Zhu, Baofang Zhang, Yiju Cheng, (unknown), Xueke Zhao, Ming-liang Cheng	37
11	A novel tree shrew model of pulmonary fibrosis 2020 ·Laboratory Investigation ·Pulin Che, (unknown), Jennifer L. Larson‐Casey, (unknown), Yiju Cheng, (unknown), Xueke Zhao, Rafael Grytz, A. Brent Carter, Qiang Ding	10
12	Gasdermin D-mediated hepatocyte pyroptosis expands inflammatory responses that aggravate acute liver failure by upregulating monocyte chemotactic protein 1/CC chemokine receptor-2 to recruit macrophages 2019 ·World Journal of Gastroenterology ·Hong Li, Xueke Zhao, Yiju Cheng, Quan Zhang, Jun Wu, Shuang Lü, Wei Zhang, Yang Liu, (unknown), Ya Wang, Jing Yang, Ming-liang Cheng	27
13	Thymosin-β4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway 2018 ·Cellular Physiology and Biochemistry ·Lili Zhu, Tingting Ren, Zixin Zhu, Mingliang Cheng, (unknown), Mao Mu, Yongmei Liu, Yumei Yao, Yiju Cheng, Baofang Zhang, Zhuo Cheng	45
14	Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis 2017 ·Scientific Reports ·Xueke Zhao, Lei Yu, Mingliang Cheng, Pulin Che, Yinying Lu, Quan Zhang, Mao Mu, Hong Li, Li Zhu, Juanjuan Zhu, Meng Hu, Po Li, (unknown), (unknown), Yiju Cheng, Zhi‐Xiang Xu, Qiang Ding	96
15	Thymosin-β4 inhibits proliferation and induces apoptosis of hepatic stellate cells through PI3K/AKT pathway 2017 ·Oncotarget ·Li Zhu, Mingliang Cheng, Yongmei Liu, Yumei Yao, Zixin Zhu, Baofang Zhang, (unknown), Yiju Cheng	7
16	Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis 2016 ·Scientific Reports ·Xueke Zhao, Yiju Cheng, Ming Cheng, Lei Yu, Mao Mu, Hong Li, Yang Liu, Baofang Zhang, Yumei Yao, Hui Guo, Rong Wang, Quan Zhang	122
17	Impact of HLA-B58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies 2016 ·Oncotarget* ·Ruiyang Wu, Yiju Cheng, Li Zhu, Lei Yu, Xueke Zhao, Min Jia, (unknown), (unknown), Ting Tang, (unknown), (unknown), (unknown), Zhi Zheng, (unknown), (unknown)	32
18	Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions 2016 ·Oncotarget ·Yiju Cheng, Ruiyang Wu, Ming-liang Cheng, Juan Du, (unknown), Lei Yu, Xueke Zhao, Yumei Yao, (unknown), Li Zhu, Juanjuan Zhu, Niwen Huang, (unknown), Yaxin Hu, Fangping Wan	23
19	Quantitative assessment of mutations in hepatitis B virus genome with liver cirrhosis and hepatocellular carcinoma development 2016 ·Oncotarget ·Lei Yu, (unknown), (unknown), Xueke Zhao, Quan Zhang, Yaxin Hu, (unknown), Mao Mu, Wang Bi, (unknown), Li Zhu, Shuai Zhang, Yumei Yao, Yiju Cheng, (unknown)	5
20	Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development 2015 ·Scientific Reports ·Lei Yu, Yiju Cheng, (unknown), Yumei Yao, Quan Zhang, Xueke Zhao, (unknown), Yaxin Hu, Mao Mu, Wang Bi, (unknown), Li Zhu, Shuai Zhang	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact